Skip to content

RAEMAT

Active Risk: not assessed Private limited companyfounded 2026active for less than a yearPoelstraat 270, 9820 Merelbeke-MelleKBO/BCE: BE 1039.614.029

Key points

No accounts filed yet

Signals

Board and ownership

Director
  • 100 sharesdeed of 02-07-2026
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1039614029
First establishment Poelstraat 270, Merelbeke-Melle
Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 02-07-2026 · Gazette deed
View the timeline

Official details

Source: KBO
Status
Active since 30-06-2026Normal situation
Activity
Specialist medical practiceNACE 86220and 4 others
Establishment unit
2.392.072.7559820 Merelbeke-Melle, since 01-07-2026
Financial year end
31 December
Peppol
Reachable since 06-08-2026
Company details

Insights on RAEMAT

RAEMAT is less than twelve months old. There is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals.

No annual accounts have been filed with the National Bank.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Key facts about RAEMAT

What is the company number of RAEMAT?
The company number of RAEMAT is 1039.614.029. The VAT number is the same number with BE in front: BE 1039.614.029.
Where is RAEMAT based?
The registered office is at Poelstraat 270, 9820 Merelbeke-Melle.Company details
What does RAEMAT do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of RAEMAT?
RAEMAT is a private limited company (BV).
When was RAEMAT founded?
RAEMAT was founded on 30-06-2026.
Is RAEMAT still active?
Yes, RAEMAT is an active enterprise in the KBO register.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.